Candel Therapeutics strengthens balance sheet as lead cancer therapy advances.
Share this article
Corporate
Score 65
Bullish
Candel Therapeutics strengthens balance sheet as lead cancer therapy advances
Mar 12, 2026 13:33 UTC
CL=F, ZM=Z, XLK
Medium term
Related Articles
Score 92
Bearish
U.S. Missile Stockpiles Depleted Amid Escalating Conflict in Iran
Mar 16, 08:00
Score 95
Bearish
War in Iran is Chewing Through American Missile Stockpiles
Mar 16, 08:00
Score 95
Bearish
Crude Prices Surge Above $100 Amid U.S. Threat to Strike Iran’s Oil Hub
Mar 16, 07:54
Score 85
Bearish
Deutsche’s FX Volatility Index Hits Eight-Month High on Iran War
Mar 16, 07:47
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.